Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 8, Pages 1786
Publisher
MDPI AG
Online
2021-04-09
DOI
10.3390/cancers13081786
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A promiscuous inflammasome sparks replication of a common tumor virus
- (2020) Eric M. Burton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NLRP1 and NLRP3 inflammasomes as a new approach to skin carcinogenesis (Review)
- (2020) Magdalena Ciążyńska et al. Oncology Letters
- Influence of concurrent chemotherapy on locoregionally advanced nasopharyngeal carcinoma treated with neoadjuvant chemotherapy plus intensity-modulated radiotherapy: A retrospective matched analysis
- (2020) Fangzheng Wang et al. Scientific Reports
- NLRP3 Inflammasome—A Key Player in Antiviral Responses
- (2020) Chunyuan Zhao et al. Frontiers in Immunology
- Caspase-11 Non-Canonical Inflammasome: Emerging Activator and Regulator of Infection-Mediated Inflammatory Responses
- (2020) Young-Su Yi INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy
- (2020) Balamayoora Theivanthiran et al. JOURNAL OF CLINICAL INVESTIGATION
- Elevated IL18 levels in Nasopharyngeal carcinoma induced PD-1 expression on NK cells in TILS leading to poor prognosis
- (2020) Anthony Kian-Fong Liou et al. ORAL ONCOLOGY
- Inflammasome and Mitophagy Connection in Health and Disease
- (2020) Jae-Min Yuk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation
- (2020) Alan Cheuk Keong Yaw et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
- (2020) David G. Pfister et al. Journal of the National Comprehensive Cancer Network
- The Role of Caspase-4 and NLRP1 in MCF7 Cell Pyroptosis Induced by hUCMSC-Secreted Factors
- (2020) Yang Jiao et al. Stem Cells International
- NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
- (2020) Shaima'a Hamarsheh et al. Frontiers in Immunology
- Inflammation and Inflammasomes: Pros and Cons in Tumorigenesis
- (2020) Liliana R. Balahura et al. Journal of Immunology Research
- Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies
- (2020) Malgorzata Sztiller-Sikorska et al. Pharmaceuticals
- Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2020) P. Bossi et al. ANNALS OF ONCOLOGY
- Cullin1 binds and promotes NLRP3 ubiquitination to repress systematic inflammasome activation
- (2019) Pin Wan et al. FASEB JOURNAL
- Early Pattern of Epstein-Barr Virus Infection in Gastric Epithelial Cells by “Cell-in-cell”
- (2019) Wenxing Yue et al. VIROLOGICA SINICA
- Effects and mechanisms of innate immune molecules on inhibiting nasopharyngeal carcinoma
- (2019) Fang Xiong et al. CHINESE MEDICAL JOURNAL
- Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
- (2019) O Hamid et al. ANNALS OF ONCOLOGY
- Epstein–Barr Virus and Innate Immunity: Friends or Foes?
- (2019) Sonia Jangra et al. Microorganisms
- Inflammasome as a promising therapeutic target for cancer
- (2019) Chaelin Lee et al. LIFE SCIENCES
- Translational genomics of nasopharyngeal cancer
- (2019) Chi Man Tsang et al. SEMINARS IN CANCER BIOLOGY
- The NLRP3 inflammasome is involved with the pathogenesis of Mayaro virus
- (2019) Luiza A. de Castro-Jorge et al. PLoS Pathogens
- Induction of Pyroptosis and Its Implications in Cancer Management
- (2019) Yan-Yang Wang et al. Frontiers in Oncology
- Incidence and mortality of nasopharyngeal carcinoma: interim analysis of a cluster randomized controlled screening trial (PRO-NPC-001) in southern China
- (2019) M F Ji et al. ANNALS OF ONCOLOGY
- Control of the inflammasome by the ubiquitin system
- (2019) Gloria Lopez‐Castejon FEBS Journal
- NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma
- (2018) Han Wang et al. BMC CANCER
- Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment
- (2018) Kyohei Nakamura et al. CANCER CELL
- IL-1 receptor antagonist controls transcriptional signature of inflammation in patients with metastatic breast cancer
- (2018) Te-Chia Wu et al. CANCER RESEARCH
- Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
- (2018) Brigette B.Y. Ma et al. JOURNAL OF CLINICAL ONCOLOGY
- An update on cell intrinsic negative regulators of the NLRP3 inflammasome
- (2018) Barun Poudel et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Sendai Virus V Protein Inhibits the Secretion of Interleukin-1β by Preventing NLRP3 Inflammasome Assembly
- (2018) Takayuki Komatsu et al. JOURNAL OF VIROLOGY
- Nasopharyngeal carcinoma: A review of current updates
- (2018) Lei Wu et al. Experimental and Therapeutic Medicine
- Expression of Caspase-1 in breast cancer tissues and its effects on cell proliferation, apoptosis and invasion
- (2018) Yanxia Sun et al. Oncology Letters
- NF-κB Signaling Regulates Epstein–Barr Virus BamHI-Q-Driven EBNA1 Expression
- (2018) Rob Verhoeven et al. Cancers
- Interleukin-1 Beta—A Friend or Foe in Malignancies?
- (2018) Rebekka Bent et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- NLRP3/Caspase-1 inflammasome activation is decreased in alveolar macrophages in patients with lung cancer
- (2018) Ismini Lasithiotaki et al. PLoS One
- Role of the NLRP3 inflammasome in cancer
- (2018) Maryam Moossavi et al. Molecular Cancer
- Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation
- (2018) Irena Kaplanov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Central Role of Inflammation Associated with Checkpoint Inhibitor Treatments
- (2018) Cristina Vajaitu et al. Journal of Immunology Research
- Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy
- (2018) Dev Karan Frontiers in Immunology
- NF-κB Signaling in Targeting Tumor Cells by Oncolytic Viruses—Therapeutic Perspectives
- (2018) Justyna Struzik et al. Cancers
- Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses
- (2017) Young-Su Yi IMMUNOLOGY
- Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
- (2017) Chiun Hsu et al. JOURNAL OF CLINICAL ONCOLOGY
- NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma
- (2017) Cong-Fa Huang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
- (2017) Donnele Daley et al. JOURNAL OF EXPERIMENTAL MEDICINE
- ARIH2 Ubiquitinates NLRP3 and Negatively Regulates NLRP3 Inflammasome Activation in Macrophages
- (2017) Akira Kawashima et al. JOURNAL OF IMMUNOLOGY
- Inflammasome antagonism by human parainfluenza virus type 3 C protein
- (2017) Niraj K. Shil et al. JOURNAL OF VIROLOGY
- An Epstein-Barr Virus MicroRNA Blocks Interleukin-1 (IL-1) Signaling by Targeting IL-1 Receptor 1
- (2017) Camille M. Skinner et al. JOURNAL OF VIROLOGY
- Enterovirus 71 Inhibits Pyroptosis through Cleavage of Gasdermin D
- (2017) Xiaobo Lei et al. JOURNAL OF VIROLOGY
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
- (2017) Paul M Ridker et al. LANCET
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma
- (2017) Z Zhai et al. ONCOGENE
- The PYRIN domain-only protein POP2 inhibits inflammasome priming and activation
- (2017) Rojo A. Ratsimandresy et al. Nature Communications
- Antigen-specific CD8+ T cell feedback activates NLRP3 inflammasome in antigen-presenting cells through perforin
- (2017) Yikun Yao et al. Nature Communications
- P2X7 receptor and NLRP3 inflammasome activation in head and neck cancer
- (2017) Ju Young Bae et al. Oncotarget
- The immune battlefield: The impact of inflammatory cytokines on CD8+ T-cell immunity
- (2017) Stephanie A. Condotta et al. PLoS Pathogens
- NLRP1 Overexpression Is Correlated with the Tumorigenesis and Proliferation of Human Breast Tumor
- (2017) Yuxian Wei et al. Biomed Research International
- Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases
- (2017) Gabriele Fenini et al. Frontiers in Pharmacology
- IL-10: A Multifunctional Cytokine in Viral Infections
- (2017) José M. Rojas et al. Journal of Immunology Research
- Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development
- (2017) Melvin Kantono et al. Frontiers in Immunology
- Gasdermin: A new player to the inflammasome game
- (2017) Erivan S. Ramos-Junior et al. Biomedical Journal
- NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria
- (2016) Zhenyu Zhong et al. CELL
- Immunotherapy against cancer-related viruses
- (2016) Haruko Tashiro et al. CELL RESEARCH
- Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor- B Signaling for Cancer Treatment
- (2016) K. P. Zeligs et al. CLINICAL CANCER RESEARCH
- GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death
- (2016) Lorenzo Sborgi et al. EMBO JOURNAL
- Inflammasome-independent NLRP3 is required for epithelial-mesenchymal transition in colon cancer cells
- (2016) Hong Wang et al. EXPERIMENTAL CELL RESEARCH
- Inflammasomes and its importance in viral infections
- (2016) Gaurav Shrivastava et al. IMMUNOLOGIC RESEARCH
- NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma
- (2016) Rob J. A. Verhoeven et al. JOURNAL OF VIROLOGY
- Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation
- (2016) Se-Lim Kim et al. MOLECULAR CANCER RESEARCH
- Activation of NLRP3 inflammasome enhances the proliferation and migration of A549 lung cancer cells
- (2016) YANLI WANG et al. ONCOLOGY REPORTS
- Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8+T cells
- (2016) Manuel Albanese et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3
- (2016) Hui Song et al. Nature Communications
- Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma
- (2016) Aditya Stanam et al. Oncotarget
- Global burden of cancers attributable to infections in 2012: a synthetic analysis
- (2016) Martyn Plummer et al. Lancet Global Health
- Linking cancer-induced Nlrp3 inflammasome activation to efficient NK cell-mediated immunosurveillance
- (2016) Maryse Dagenais et al. OncoImmunology
- Targeting inflammasome/IL-1 pathways for cancer immunotherapy
- (2016) Beichu Guo et al. Scientific Reports
- The PYRIN Domain-only Protein POP1 Inhibits Inflammasome Assembly and Ameliorates Inflammatory Disease
- (2015) Lucia de Almeida et al. IMMUNITY
- The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity
- (2015) Jeremy Dupaul-Chicoine et al. IMMUNITY
- Lipopolysaccharide Primes the NALP3 Inflammasome by Inhibiting Its Ubiquitination and Degradation Mediated by the SCFFBXL2E3 Ligase
- (2015) SeungHye Han et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
- (2015) Stefano Ugel et al. JOURNAL OF CLINICAL INVESTIGATION
- The NLRP1 Inflammasome Attenuates Colitis and Colitis-Associated Tumorigenesis
- (2015) Tere M. Williams et al. JOURNAL OF IMMUNOLOGY
- EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma
- (2015) Zhi Li et al. Oncotarget
- Parthenolide Inhibits Cancer Stem-Like Side Population of Nasopharyngeal Carcinoma Cells via Suppression of the NF-κB/COX-2 Pathway
- (2015) Kun Liao et al. Theranostics
- Reciprocal Regulation between Enterovirus 71 and the NLRP3 Inflammasome
- (2015) Hongbin Wang et al. Cell Reports
- Inflammasome control of viral infection
- (2015) Christopher Lupfer et al. Current Opinion in Virology
- Andrographolide Suppresses Proliferation of Nasopharyngeal Carcinoma Cells via Attenuating NF-κB Pathway
- (2015) Tao Peng et al. Biomed Research International
- Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer
- (2014) Wenjie Guo et al. Autophagy
- The interplay between Epstein–Barr virus and B lymphocytes: implications for infection, immunity, and disease
- (2014) Olivia L. Hatton et al. IMMUNOLOGIC RESEARCH
- Epstein-Barr Virus Large Tegument Protein BPLF1 Contributes to Innate Immune Evasion through Interference with Toll-Like Receptor Signaling
- (2014) Michiel van Gent et al. PLoS Pathogens
- The role of the IKK complex in viral infections
- (2014) Moushimi Amaya et al. Pathogens and Disease
- NF- B, an Active Player in Human Cancers
- (2014) Y. Xia et al. Cancer Immunology Research
- Virus induced inflammation and cancer development
- (2013) Scott A. Read et al. CANCER LETTERS
- miR-197 Expression in Peripheral Blood Mononuclear Cells from Hepatitis B Virus-Infected Patients
- (2013) Li Chen et al. Gut and Liver
- Caspase-1: The inflammasome and beyond
- (2013) Gabriel Sollberger et al. Innate Immunity
- Proteasomal Degradation of Herpes Simplex Virus Capsids in Macrophages Releases DNA to the Cytosol for Recognition by DNA Sensors
- (2013) K. A. Horan et al. JOURNAL OF IMMUNOLOGY
- Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma
- (2013) Grace Tin-Yun Chung et al. JOURNAL OF PATHOLOGY
- Constitutive Interferon-Inducible Protein 16-Inflammasome Activation during Epstein-Barr Virus Latency I, II, and III in B and Epithelial Cells
- (2013) M. A. Ansari et al. JOURNAL OF VIROLOGY
- Epstein-Barr Virus Deubiquitinase Downregulates TRAF6-Mediated NF- B Signaling during Productive Replication
- (2013) S. Saito et al. JOURNAL OF VIROLOGY
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Interleukin-1β in innate inflammation, autophagy and immunity
- (2013) Leo A.B. Joosten et al. SEMINARS IN IMMUNOLOGY
- NF-κB and IRF7 Pathway Activation by Epstein-Barr Virus Latent Membrane Protein 1
- (2013) Ina Ersing et al. Viruses-Basel
- Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers
- (2013) Mallikarjuna Pichika et al. OncoTargets and Therapy
- Post-Translational Control of IL-1β via the Human Papillomavirus Type 16 E6 Oncoprotein: A Novel Mechanism of Innate Immune Escape Mediated by the E3-Ubiquitin Ligase E6-AP and p53
- (2013) Martina Niebler et al. PLoS Pathogens
- Pyrin- and CARD-only Proteins as Regulators of NLR Functions
- (2013) Hongnga T. Le et al. Frontiers in Immunology
- Interleukin-18 and IL-18 Binding Protein
- (2013) Charles A. Dinarello et al. Frontiers in Immunology
- NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens
- (2012) Yikun Yao et al. CELL RESEARCH
- Tumour inflammasome-derived IL-1β recruits neutrophils and improves local recurrence-free survival in EBV-induced nasopharyngeal carcinoma
- (2012) Lih-Chyang Chen et al. EMBO Molecular Medicine
- Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation
- (2012) Christine Juliana et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inflammasomes and viruses: cellular defence versus viral offence
- (2012) A. M. Gram et al. JOURNAL OF GENERAL VIROLOGY
- NLRP3 Inflammasome Activity Is Negatively Controlled by miR-223
- (2012) F. Bauernfeind et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1 Production
- (2012) M. Haneklaus et al. JOURNAL OF IMMUNOLOGY
- Parthenolide induces apoptosis and lytic cytotoxicity in Epstein-Barr virus-positive Burkitt lymphoma
- (2012) YUAN LI et al. Molecular Medicine Reports
- Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction
- (2012) Chong-Shan Shi et al. NATURE IMMUNOLOGY
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination
- (2012) Simon Jochum et al. PLoS Pathogens
- Inhibitory kappa B kinases as targets for pharmacological regulation
- (2011) Carly Gamble et al. BRITISH JOURNAL OF PHARMACOLOGY
- IL-18 Induces PD-1-Dependent Immunosuppression in Cancer
- (2011) M. Terme et al. CANCER RESEARCH
- The inflammasome: in memory of Dr. Jurg Tschopp
- (2011) M Dagenais et al. CELL DEATH AND DIFFERENTIATION
- From virus to inflammation: Mechanisms of RIG-I-induced IL-1β production
- (2011) Hendrik Poeck et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Modulation of Inflammasome Pathways by Bacterial and Viral Pathogens
- (2011) M. Lamkanfi et al. JOURNAL OF IMMUNOLOGY
- Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial
- (2011) Qiu-Yan Chen et al. JNCI-Journal of the National Cancer Institute
- Epstein-Barr Virus Zta-Induced Immunomodulators from Nasopharyngeal Carcinoma Cells Upregulate Interleukin-10 Production from Monocytes
- (2011) C.-H. Lee et al. JOURNAL OF VIROLOGY
- Epstein-Barr Virus Infection of Polarized Epithelial Cells via the Basolateral Surface by Memory B Cell-Mediated Transfer Infection
- (2011) Claire Shannon-Lowe et al. PLoS Pathogens
- The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental Colitis
- (2010) Md. Hasan Zaki et al. IMMUNITY
- The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer
- (2010) Irving C. Allen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-18 Production Downstream of the Nlrp3 Inflammasome Confers Protection against Colorectal Tumor Formation
- (2010) M. H. Zaki et al. JOURNAL OF IMMUNOLOGY
- Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome
- (2010) Kiichi Nakahira et al. NATURE IMMUNOLOGY
- Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44
- (2009) J. S. Kang et al. CARCINOGENESIS
- The NLRP3 Inflammasome Mediates In Vivo Innate Immunity to Influenza A Virus through Recognition of Viral RNA
- (2009) Irving C. Allen et al. IMMUNITY
- Constitutively Active Inflammasome in Human Melanoma Cells Mediating Autoinflammation via Caspase-1 Processing and Secretion of Interleukin-1β
- (2009) Miyako Okamoto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Virus-Encoded Homologs of Cellular Interleukin-10 and Their Control of Host Immune Function
- (2009) B. Slobedman et al. JOURNAL OF VIROLOGY
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- Stage-Specific Inhibition of MHC Class I Presentation by the Epstein-Barr Virus BNLF2a Protein during Virus Lytic Cycle
- (2009) Nathan P. Croft et al. PLoS Pathogens
- EBV in Hodgkin Lymphoma
- (2009) Giuseppina Massini et al. Mediterranean Journal of Hematology and Infectious Diseases
- Thalidomide for treatment of multiple myeloma: 10 years later
- (2008) A. Palumbo et al. BLOOD
- The distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer types
- (2008) AS Abdulamir et al. BMC PUBLIC HEALTH
- Nasopharyngeal carcinoma—Review of the molecular mechanisms of tumorigenesis
- (2008) Josephine Chou et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Epstein-Barr Virus Lytic Transactivator Zta Enhances Chemotactic Activity through Induction of Interleukin-8 in Nasopharyngeal Carcinoma Cells
- (2008) M. Hsu et al. JOURNAL OF VIROLOGY
- Epstein-Barr virus and Burkitt lymphoma
- (2007) G Brady et al. POSTGRADUATE MEDICAL JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search